Lidds AB
LIDDS
Overview
Corporate Details
- ISIN(s):
- SE0001958612
- LEI:
- 549300YYW8B918K7UN72
- Country:
- Sweden
- Address:
- Box 12040, 112 40 Stockholm
- Website:
- https://liddspharma.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Lidds AB develops innovative drug delivery technologies for cancer treatment.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-02-14 | Anders Månsson | Other | Buy | 100,000 | 140,000.00 SEK |
| 2023-02-10 | Matthew Lindon | Other | Buy | 71,428 | 99,999.20 SEK |
| 2023-02-09 | Daniel Lifveredson | Other | Other | 150,000 | 210,000.00 SEK |
| 2022-12-16 | Daniel Lifveredson | Other | Sell | 435,254 | 826,982.60 SEK |
| 2022-12-16 | Daniel Lifveredson | Other | Buy | 435,254 | 826,982.60 SEK |
| 2022-06-02 | Galba Holding AB | Other | Buy | 750,000 | 4,500,000.00 SEK |
| 2022-03-08 | Jan Törnell | Other | Buy | 5,000 | 32,500.00 SEK |
| 2021-06-30 | Nina Herne | Other | Other | 100,000 | 116,000.00 SEK |
| 2021-06-03 | Daniel Lifveredson | Other | Buy | 435,254 | 4,483,116.20 SEK |
| 2021-05-31 | Maria Forss | Other | Buy | 2,300 | 29,992.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Herantis Pharma Oyj | Finland | HRTIS | |
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Inify Laboratories AB | Sweden | INIFY | |
|
Innate Pharma | France | IPH |